ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie
Major venture capital investment in European life sciences will fuel occupier market
Odyssey buys BenevolentAI in Europe's top SPAC deal
Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design
Platform that Offers AI Investment Advice MDOTM Raises €6.2 million Series B, Currently holds € 750 million AUA
Exscientia Files For $100M IPO
Analysts compile top European biotech news of 2021
Innovation at the intersection of design and technology
Pfizer and PostEra collab in $250M AI lab deal
Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
